Comparative genomics allowed the identification of drug targets against human fungal pathogens.
about
Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus speciespH signaling in human fungal pathogens: a new target for antifungal strategiesDe novo GTP Biosynthesis Is Critical for Virulence of the Fungal Pathogen Cryptococcus neoformansComparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidatesExoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compoundsAnalysis of the protein domain and domain architecture content in fungi and its application in the search of new antifungal targetsIdentification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides GenusGPCRs from fusarium graminearum detection, modeling and virtual screening - the search for new routes to control head blight diseaseAntifungal drug discovery: the process and outcomes.Genome-wide Analysis of Mycoplasma hominis for the Identification of Putative Therapeutic Targets.Allergens/Antigens, toxins and polyketides of important Aspergillus species.Prevalence of transcription factors in ascomycete and basidiomycete fungi.Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosisEssential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritizationAn ensemble framework for identifying essential proteins.Photodynamic inactivation of Paracoccidioides brasiliensis helps the outcome of oral paracoccidiodomycosis.Candida albicans: A Model Organism for Studying Fungal Pathogens.Endemic mycoses in immunocompromised hosts.Exploitation of genomics in fungicide research: current status and future perspectives.Conservation in Aspergillus fumigatus of pH-signaling seven transmembrane domain and arrestin proteins, and implications for drug discovery.Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues.Early state research on antifungal natural products.Evolutionary Perspectives on Human Fungal Pathogens.Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum.Identification and Evaluation of Novel Drug Targets against the Human Fungal Pathogen Aspergillus fumigatus with Elaboration on the Possible Role of RNA-Binding Protein.Antifungal therapeutics for dimorphic fungal pathogens.Targeting the Homoserine Dehydrogenase of Paracoccidioides Species for Treatment of Systemic Fungal Infections.Retrieval of Enterobacteriaceae drug targets using singular value decomposition.An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriae.Isolation of a new broad spectrum antifungal polyene from Streptomyces sp. MTCC 5680.Mutual independence of alkaline- and calcium-mediated signalling in Aspergillus fumigatus refutes the existence of a conserved druggable signalling nexus.A new small-molecule KRE2 inhibitor against invasive Candida parapsilosis infection.
P2860
Q26748172-03CE8824-A57D-4708-BEB1-52CC21D91AAEQ26830123-0E62213F-515D-4423-9B1A-5267BBB4E3C4Q27674590-FCC3043A-C46A-49F2-B80F-1AE48FED2CC0Q28482216-EF03C90C-E099-44B0-952C-078F7F9139D0Q28485375-D9BB2841-9799-42C3-8495-529AD54AEAB2Q28540822-670EAE86-404C-4542-A6F6-4EA6152B5737Q28550999-683B1F60-3E61-48C5-AB36-6DDCA28CC44FQ28818657-5B6B93B7-48E7-460A-8F43-B4283D3739E2Q34086897-6FE911A9-699B-439F-81CB-004CE9800355Q34680309-5EB521CC-40BE-4CAE-AC69-949BD94319CDQ35022360-399F432D-BD49-4670-85D1-3B0A913F53C3Q35125912-3BD58F00-3170-4FB9-BBBF-CED503B3F39EQ35540681-DAAF3BA3-10E9-4E89-8DFB-E9098702A504Q35677545-5A34F643-C585-4E98-A102-66037ACA7159Q36112067-0618BF3A-FCB7-41AD-9284-87EA8B1FAE4AQ36324972-2F9E860D-3008-4598-9232-63D461A8A5DEQ36900101-98E96869-1505-4C71-A695-45EFB4EC0221Q37080529-9893A4D0-BB6A-415D-9185-3050C45F8270Q38060200-D1F1EB48-B4AF-4F4C-9EAC-7D69BB4760D1Q38066513-6BCD3595-286C-4C49-B398-2806CB3219B5Q38135905-0BE9B839-8E5E-4C8C-96BE-74BBB02A7836Q38194442-11AE5295-A6B1-411C-81CD-394BAD83CE9EQ38266677-01B40197-0F5D-4011-A008-FFB38A326846Q38668190-68E86CBC-06C5-4AB3-A9ED-B38AF4109707Q38779848-14F085CC-3EEA-465D-8753-CC2445FB4071Q38959083-DAF2E952-15FF-4596-B4EA-F0E68D024E02Q40157282-E6F1BE90-3964-48E9-932B-340B5F9E3E48Q41722339-D8D3FF82-B715-4ED4-B96D-515C7A2B9175Q45070482-5D059257-C1F8-49DB-9B35-EBE47A4A4D61Q45340225-A11DDDB3-026E-413C-A301-05F6D080127DQ47349931-BC4D3486-A6EF-4D52-91EE-A78A7392B439Q47702018-0E4DF0C1-3BDA-4459-94A7-EBDC116BB7C5
P2860
Comparative genomics allowed the identification of drug targets against human fungal pathogens.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparative genomics allowed t ...... gainst human fungal pathogens.
@ast
Comparative genomics allowed t ...... gainst human fungal pathogens.
@en
type
label
Comparative genomics allowed t ...... gainst human fungal pathogens.
@ast
Comparative genomics allowed t ...... gainst human fungal pathogens.
@en
prefLabel
Comparative genomics allowed t ...... gainst human fungal pathogens.
@ast
Comparative genomics allowed t ...... gainst human fungal pathogens.
@en
P2093
P2860
P921
P356
P1433
P1476
Comparative genomics allowed t ...... gainst human fungal pathogens.
@en
P2093
Ana Karina R Abadio
Bernard Maigret
Erika S Kioshima
Marcus M Teixeira
Maria Sueli S Felipe
Natalia F Martins
P2860
P2888
P356
10.1186/1471-2164-12-75
P407
P577
2011-01-27T00:00:00Z
P5875
P6179
1001258522